Logotype for biote Corp

biote Corp (BTMD) investor relations material

biote Corp Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for biote Corp
Q2 2025 earnings summary6 Aug, 2025

Executive summary

  • Q2 2025 performance was driven by strong dietary supplement sales and gross margin expansion, despite a slight year-over-year revenue decrease and lower procedure volumes.

  • Comprehensive organizational restructuring launched in May 2025 included leadership changes, sales team rebuild, and workforce reduction to drive sustainable growth and accountability.

  • Cost savings from vertical integration and restructuring improved profitability, with a $0.6M one-time restructuring charge in Q2 2025.

  • CEO transition occurred in February 2025, with the new CEO appointed and the former CEO moving to an advisory role.

  • Initial progress seen in commercial and foundational priorities, but changes have been disruptive, particularly to procedure-related sales.

Financial highlights

  • Q2 2025 revenue was $48.9M, down slightly year-over-year, with an 8.4% decrease in procedure revenue offset by 30%+ growth in dietary supplements.

  • Gross profit margin improved to 71.6%, up 280 basis points, driven by cost savings from vertical integration.

  • SG&A expenses decreased 12.2% to $24.2M, aided by lower employee, consulting, and legal costs.

  • Net income was $3.9M (EPS $0.10), compared to a net loss of $10.4M (EPS $(0.21)) in Q2 2024.

  • Adjusted EBITDA rose 19.1% to $15.2M, with margin increasing to 31.1% from 25.9% year-over-year.

  • Cash and equivalents at June 30, 2025 were $19.6M, down from $41.7M at 3/31/2025 and $39.3M at 12/31/2024.

Outlook and guidance

  • Fiscal 2025 revenue guidance revised to above $190M, down from prior $202–$208M; adjusted EBITDA now expected above $50M, down from $59–$64M.

  • Procedure revenue forecasted to decline by high single digits for the year; dietary supplement revenue expected to grow in the mid-teens percentage.

  • Second half trends in procedure revenue anticipated to mirror Q2, with strong but moderating dietary supplement growth.

  • Management expects continued growth in dietary supplements and service revenue, with ongoing cost control and supply chain optimization.

  • The company believes current liquidity and cash flow are sufficient to fund operations and debt service for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next biote Corp earnings date

Logotype for biote Corp
Q3 202511 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next biote Corp earnings date

Logotype for biote Corp
Q3 202511 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Biote Corp. is a healthcare company focused on the medical practice-building business within the hormone optimization space. Founded in 2012 and headquartered in Irving, Texas, Biote Corp. specializes in offering a platform for Biote-certified practitioners. This platform is designed to help practitioners optimize their patients' hormone, vitamin, and mineral levels. Additionally, Biote Corp. enables the prescription of bioidentical hormone therapies and recommends dietary supplements. The company also markets Biote-branded dietary supplements and sterile pellet insertion kits, which are used alongside hormone optimization therapies for both male and female patients. The company is headquartered in Irving, Texas, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage